Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP)

Faehling, M. and Schumann, C. and Christopoulos, P. and Hoffknecht, P. and Alt, J. and Horn, M. and Eisenmann, S. and Schlenska-Lange, A. and Aries, S. P. and Sackmann, S. and Schuett, P. and Steger, F. and Christoph, D. (2020) Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP). In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Petra Gürster
Date Deposited: 16 Apr 2021 05:12
Last Modified: 16 Apr 2021 05:12
URI: https://pred.uni-regensburg.de/id/eprint/43890

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.